SALVARANI, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 53.022
EU - Europa 19.704
AS - Asia 5.541
SA - Sud America 106
OC - Oceania 100
AF - Africa 84
Continente sconosciuto - Info sul continente non disponibili 42
Totale 78.599
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 52.499
GB - Regno Unito 7.933
IT - Italia 3.720
CN - Cina 2.343
SE - Svezia 2.180
DE - Germania 1.563
HK - Hong Kong 1.492
UA - Ucraina 1.448
TR - Turchia 1.074
FI - Finlandia 921
BG - Bulgaria 749
FR - Francia 399
CA - Canada 253
BZ - Belize 221
IE - Irlanda 193
JP - Giappone 156
NL - Olanda 156
IN - India 114
RU - Federazione Russa 84
AU - Australia 83
VN - Vietnam 73
ES - Italia 61
BE - Belgio 50
SG - Singapore 47
CH - Svizzera 46
MX - Messico 40
KR - Corea 39
EU - Europa 38
CZ - Repubblica Ceca 37
IR - Iran 37
MY - Malesia 35
PK - Pakistan 35
BR - Brasile 31
PL - Polonia 31
TN - Tunisia 27
AR - Argentina 22
EG - Egitto 21
ID - Indonesia 20
CO - Colombia 19
PT - Portogallo 18
NZ - Nuova Zelanda 17
HU - Ungheria 16
RO - Romania 15
GR - Grecia 14
IL - Israele 13
RS - Serbia 13
CL - Cile 12
PE - Perù 12
PH - Filippine 11
AT - Austria 10
DK - Danimarca 9
IQ - Iraq 9
MA - Marocco 9
EC - Ecuador 8
TW - Taiwan 8
ZA - Sudafrica 8
JO - Giordania 7
KE - Kenya 7
NO - Norvegia 6
DZ - Algeria 5
LT - Lituania 5
LU - Lussemburgo 5
TH - Thailandia 5
BD - Bangladesh 4
EE - Estonia 4
GH - Ghana 4
HR - Croazia 4
NP - Nepal 4
SA - Arabia Saudita 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
GT - Guatemala 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
BY - Bielorussia 2
CU - Cuba 2
LB - Libano 2
LV - Lettonia 2
LY - Libia 2
MK - Macedonia 2
SI - Slovenia 2
A1 - Anonimo 1
AL - Albania 1
BN - Brunei Darussalam 1
CY - Cipro 1
GL - Groenlandia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
MM - Myanmar 1
MT - Malta 1
PY - Paraguay 1
SY - Repubblica araba siriana 1
UG - Uganda 1
VE - Venezuela 1
Totale 78.599
Salva come PNG Salva come JPEG
Città #
Fairfield 8.611
Southend 6.696
Woodbridge 5.935
Houston 4.029
Ashburn 3.742
Chandler 3.410
Seattle 3.133
Wilmington 2.811
Jacksonville 2.750
Cambridge 2.624
Ann Arbor 2.339
Dearborn 1.911
Hong Kong 1.479
Modena 1.295
Nyköping 1.168
San Diego 986
Beijing 971
Princeton 777
Sofia 738
Eugene 560
San Jose 532
Helsinki 459
New York 453
Izmir 414
London 324
Belize City 221
Redwood City 198
Milan 179
Dublin 168
Las Vegas 161
Bologna 144
Chicago 134
Buffalo 127
Boardman 121
Toronto 114
Rome 110
Norwalk 108
Falls Church 105
Dallas 103
Shanghai 101
Saint Louis 96
Bremen 95
Hefei 88
Nanjing 84
Kilburn 80
Reggio Nell'emilia 79
Kunming 67
Dong Ket 66
Frankfurt am Main 64
Albuquerque 62
Hounslow 57
Tokyo 56
Atlanta 53
Chiswick 52
Columbus 49
Perth 46
Jinan 43
Guangzhou 41
Padova 41
Reggio Emilia 39
North York 38
Parma 37
Prescot 37
Brussels 36
Des Moines 34
Ankara 32
Florence 32
Vigevano 30
Brno 28
Grafing 28
Munich 28
Nanchang 28
Verona 28
Indiana 27
Ottawa 27
Shenyang 27
Zurich 27
Los Angeles 26
Council Bluffs 25
Paris 25
Mumbai 24
Santa Clara 23
Valencia 23
Moscow 22
Groningen 21
Islington 21
Naples 20
San Francisco 20
Wuhan 20
Zhengzhou 20
Hebei 19
Southwark 19
Washington 19
Bari 18
San Mateo 18
Chengdu 17
Fuzhou 17
Hangzhou 17
Wandsworth 17
Castenaso 15
Totale 62.489
Salva come PNG Salva come JPEG
Nome #
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 790
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 338
Anti-TNF-α drugs differently affect the TNFa-sTNFR system and monocyte subsets in patients with psoriasis 290
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 259
Corrigendum: Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy 255
Comment on: Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis: Reply 254
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 252
Adult Primary Central Nervous System Vasculitis 244
Prevalence of SARS-CoV-2 (Covid-19) in Italians and in immigrants in an area of Northern Italy (Reggio Emilia) 231
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis 228
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 224
CC chemokine receptor 5 polymorphism in Italian patients with Behcet's disease 223
Clinical features of polymyalgia rheumatica and giant cell arteritis 215
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice 203
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 201
G/R 241 polymorphism of intercellular adhesion molecule 1 (ICAM-1) is associated with Fuchs uveitis 200
Thalidomide, deep venous thrombosis and vasculitis 198
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 192
Clinical Spectrum of Medium-Sized Vessel Vasculitis 192
Interferon Alpha-2a for the Treatment of Post-Infectious Uveitis Secondary to Presumed Intraocular Tuberculosis 186
Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study 185
Rituximab therapy for Takayasu arteritis: A seven patients experience and a review of the literature 184
Recent advances in the diagnosis and treatment of polymyalgia rheumatica 184
Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature 183
-463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis 183
(18)F-fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis 181
Visual loss and other cranial ischaemic complications in giant cell arteritis 181
2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative 179
Venous Thromboembolism and Cerebrovascular Events in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study 179
Histopathologic Findings of Patients With Biopsy-Negative Giant Cell Arteritis Compared to Those Without Arteritis: A Population-Based Study 178
Biotherapies in large vessel vasculitis 176
Contrast-enhanced ultrasound of the carotid artery in patients with large vessel vasculitis: Correlation with positron emission tomography findings 176
A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility 175
Epidemiology of psoriatic arthritis 175
Higher Frequencies of Lymphocytes Expressing the Natural Killer Group 2D Receptor in Patients With Behçet Disease 173
Validation of the classification criteria for cryoglobulinaemic vasculitis 172
An Italian shared dermatological and rheumatological proposal for the use of biological agents in psoriatic disease 172
Improving therapeutic options for patients with giant cell arteritis 172
Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study 172
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 172
Comparison between colour duplex sonography findings and different histological patterns of temporal artery 171
2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative 170
[18F]fluorodeoxyglucose positron emission tomography imaging in a case of relapsing polychondritis 169
Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs 168
Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study 167
Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study 167
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 167
Musculoskeletal manifestations in a population-based cohort of patients with giant cell arteritis 166
Management of primary and secondary central nervous system vasculitis 166
Are steroids alone sufficient for the treatment of giant cell arteritis? 166
Symptomatic psoriatic dactylitis is associated with ultrasound determined extra-synovial inflammatory features and shorter disease duration 166
Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis 165
Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine 165
Trial of Tocilizumab in Giant-Cell Arteritis 165
Imaging of vasculitis: State of the art 165
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides 164
Difference in the expression of IL-9 and IL-17 correlates with different histological pattern of vascular wall injury in giant cell arteritis 164
Relationship between plasma profiles of oxytocin and adrenocorticotropic hormone during suckling or breast stimulation in women 164
NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica 163
Whole Exome Sequencing Identifies Rare Protein-Coding Variants in Behçet's Disease 163
Large-Vessel Dilatation in Giant Cell Arteritis: A Different Subset of Disease? 163
Tocilizumab: a novel therapy for patients with large-vessel vasculitis 162
The role of infectious agents in the pathogenesis of vasculitis 162
Canakinumab in a case of adult onset still's disease: efficacy only on systemic manifestations 161
Long-term remission in biopsy proven giant cell arteritis: A retrospective cohort study 161
MicroRNA markers of inflammation and remodelling in temporal arteries from patients with giant cell arteritis 160
2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative 159
Newly diagnosed vs. relapsing giant cell arteritis: Baseline data from the GiACTA trial 159
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study 159
Primary CNS vasculitis with spinal cord involvement 159
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease 159
Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease 159
Increased expression of interleukin-22 in patients with giant cell arteritis 158
Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study 158
A putative functional variant within the UBAC2 gene is associated with increased risk of Behçet's disease 157
Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study 157
Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature 156
Biologics in vasculitides: Where do we stand, where do we go from now? 156
Incidence, prevalence and survival of biopsy-proven giant cell arteritis in Northern Italy during a 26-year period 156
Rapidly progressive primary central nervous system vasculitis 156
Psoriatic arthritis spondylitis radiology index: a modified index for radiologic assessment of axial involvement in psoriatic arthritis 155
Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis 155
CC chemokine receptor 5 polymorphism in Italian patients with giant cell arteritis 155
Impact of demography and population dynamics on the genetic architecture of human longevity 155
Role of PD-L1 in licensing immunoregulatory function of dental pulp mesenchymal stem cells 155
VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis 155
Cervical interspinous bursitis in active polymyalgia rheumatica 154
Complex interplay between neutral and adaptive evolution shaped differential genomic background and disease susceptibility along the Italian peninsula 154
Idiopathic aortitis: an underrecognized vasculitis 154
Aortic dilatation in patients with large vessel vasculitis: A longitudinal case control study using PET/CT 154
Giant cell arteritis: Involvement of intracranial arteries 153
Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis 153
Criteria, frequency, and duration of clinical remission in psoriatic arthritis patients with peripheral involvement requiring second-line drugs 153
Positron emission tomography (PET): evaluation of chronic periaortitis 152
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis 152
Pre-pregnancy counselling of patients with vasculitis 152
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 152
Polymyalgia rheumatica and giant-cell arteritis 151
IL-23A, IL-23R, IL-17A and IL-17R polymorphisms in different psoriatic arthritis clinical manifestations in the northern Italian population 151
Detection of parvovirus B19 DNA by polymerase chain reaction in giant cell arteritis: a case-control study 151
Totale 18.291
Salva come PNG Salva come JPEG
Categoria #
all - tutte 348.031
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 348.031
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193.631 0 0 0 0 0 0 0 0 0 0 1.953 1.678
2019/202016.757 1.509 626 428 933 2.125 2.634 3.044 1.749 1.702 622 971 414
2020/202115.857 1.387 927 1.146 1.847 1.511 1.125 1.429 1.947 1.016 1.604 919 999
2021/202213.164 620 1.475 1.334 950 369 965 861 631 1.513 943 2.021 1.482
2022/202310.863 1.386 756 738 798 1.307 1.559 243 1.046 1.697 225 597 511
2023/20246.916 335 532 425 849 1.815 486 515 1.469 246 216 28 0
Totale 80.401